Article thumbnail

MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

By Nagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, Yezi Zhu, Xu-Bao Shi, June X. Zou, Hongwu Chen, Jin Zhang, Xinbin Chen, Jun Luo, Ralph W. deVere White, Hsing-Jien Kung, Christopher P. Evans and Allen C. Gao
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3316551
Provided by: PubMed Central

Suggested articles

Citations

  1. (2006). A novel role of myosin VI in human prostate cancer.
  2. (2010). a sub-population of stem cell-like cells in ovarian cancer.
  3. (2010). Aberrant Activation of the Androgen Receptor by NF-kappaB2/p52 in Prostate Cancer Cells.
  4. (2009). An epigenetic switch involving NFk a p p a B ,L i n 2 8 ,L e t - 7m i c r o R N Aa n dI L 6l i n k si n f l a m m a t i o nt oc e l l transformation
  5. (2008). Cancerous miRNAs and their regulation
  6. (2009). CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma - A miRNA microarray analysis.
  7. (2007). Dutta A
  8. (2009). Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
  9. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
  10. (2007). Impaired microRNA processing enhances cellular transformation and tumorigenesis.
  11. (2003). Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.
  12. (2007). Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
  13. (2007). let-7 regulates self-renewal and tumorigenicity of breast cancer cells
  14. (2008). Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
  15. (2009). Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.
  16. (2009). Lin28 promotes transformation and is associated with advanced human malignancies.
  17. (2010). Lin28: A microRNA regulator with a macro role
  18. (2009). Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.
  19. (2005). MicroRNA expression profiles classify human cancers.
  20. (2010). MicroRNA let-7: an emerging next-generation cancer therapeutic.
  21. (2010). MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and
  22. (2011). MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
  23. (2009). MicroRNAs and prostate cancer. Endocr Relat Cancer:
  24. (2007). MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer Therapy.
  25. (2008). NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
  26. (2009). Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
  27. (2005). Real-time expression profiling of microRNA precursors in human cancer cell lines.
  28. (2004). Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival.
  29. (2010). Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor.
  30. (2008). The let-7 microRNA reduces tumor growth in mouse models of lung cancer
  31. (2010). The role of let7 in cell differentiation and cancer.
  32. (2009). Towards the definition of prostate cancer-related microRNAs: where are we now? Trends in
  33. (2007). Widespread deregulation of microRNA expression in human prostate cancer.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.